In exciting news, Vivus announced that it intends to resubmit its weight-loss drug Qnexa to the FDA for review by the end of October. As a reminder, in October 2010, the...

We always love attending the ADA Postgrad meeting – an update for doctors and nurses on new practices in diabetes.

In late March, the International Diabetes Federation (IDF) released a "position statement" recommending the consideration of bariatric surgery to treat type 2 diabetes...

Kerri Morrone Sparling reflects on the true meaning of ‘need’ in the global diabetes community…

Earlier this month, the FDA chose not to approve Bristol-Myers Squibb/AstraZeneca’s dapagliflozin, a member of a class of drugs that causes users to excrete excess...

Nine year-old Boaz Alkalay offers a rare glimpse of diabetes through the eyes of a child.

JDRF is offering a $100,000 prize for innovative ideas on how to develop a glucose-responseive insulin Earlier this month, JDRF announced that it would award a $100,000...

Dr. Lawrence Soler writes a letter of concern to the New York Times .

Recently, we learned that the Japan-based pharmaceutical company Takeda has submitted its type 2 diabetes therapy alogliptin for approval in the US. The therapy has been...

Kelly’s take on the maddeningly slow FDA approval process and why things are probably getting better.

In October 2010, Biocon, an Indian pharmaceutical company, and Pfizer partnered to develop and market biosimilar insulin analogs (see NewNowNext in diaTribe #26). A...

The 2007 AADE in August in St. Louis was extremely educational, as always.

Earlier in April, Biodel management updated the timeline for the development of its ultra-rapid-acting insulin candidates. As a reminder, in October 2010 the company's...

Diabetes on stage: Jim Hirsch tells us about Robbie McCauley’s powerful one-woman production, “Sugar."

Recently, we were excited to hear that Sanofi/AgaMatrix have received FDA clearance for the iBGStar , the first blood glucose monitor that connects directly to an Apple...

While the pharmaceutical industry continues to offer new products, it has been over two years since the FDA has approved a diabetes medication with a completely novel...

The Diabetes Barometer

April has been quite a busy month for Medtronic with the launch of new CareLink software that is finally Mac-compatible and the introduction of the greatly anticipated...

Kelly reflects on 25 years with diabetes, and her hopes for future breakthroughs…

If you’ve been following our coverage of Orexigen’s obesity drug, Contrave, you’re likely aware that it has been through a regulatory rollercoaster over the past few...